Covered recipient · General Payments record
SAMUEL ROBERT ALTHAUSER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2019–2024
$3,472.62
- Reported across 229 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $412.61 | 38 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $279.84 | 32 |
| Alkermes, Inc. | $43.61 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $36.62 | 2 |
| ITI, Inc. | $29.06 | 1 |
| ACADIA Pharmaceuticals Inc | $23.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (38)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.76 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213089 | CMS |
| ABBVIE INC. | $2.11 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213091 | CMS |
| ABBVIE INC. | $10.42 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213093 | CMS |
| ABBVIE INC. | $2.63 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213095 | CMS |
| ABBVIE INC. | $6.96 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213097 | CMS |
| ABBVIE INC. | $6.55 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213099 | CMS |
| ABBVIE INC. | $8.34 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213101 | CMS |
| ABBVIE INC. | $7.53 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213103 | CMS |
| ABBVIE INC. | $8.72 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213105 | CMS |
| ABBVIE INC. | $5.82 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213107 | CMS |
| ABBVIE INC. | $4.56 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213109 | CMS |
| ABBVIE INC. | $10.29 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213111 | CMS |
| ABBVIE INC. | $8.07 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213113 | CMS |
| ABBVIE INC. | $2.57 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213115 | CMS |
| ABBVIE INC. | $28.22 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213117 | CMS |
| ABBVIE INC. | $4.21 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213119 | CMS |
| ABBVIE INC. | $9.90 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213121 | CMS |
| ABBVIE INC. | $8.80 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213123 | CMS |
| ABBVIE INC. | $8.06 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213125 | CMS |
| ABBVIE INC. | $6.23 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213127 | CMS |
| ABBVIE INC. | $8.80 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213129 | CMS |
| ABBVIE INC. | $13.14 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213131 | CMS |
| ABBVIE INC. | $10.36 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213133 | CMS |
| ABBVIE INC. | $8.12 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213135 | CMS |
| ABBVIE INC. | $3.20 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213137 | CMS |
| ABBVIE INC. | $11.47 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213139 | CMS |
| ABBVIE INC. | $9.56 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213141 | CMS |
| ABBVIE INC. | $8.84 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213143 | CMS |
| ABBVIE INC. | $4.31 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213145 | CMS |
| ABBVIE INC. | $7.36 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213147 | CMS |
| ABBVIE INC. | $25.77 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213149 | CMS |
| ABBVIE INC. | $11.16 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103213151 | CMS |
| ACADIA Pharmaceuticals Inc | $23.48 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147961239 | CMS |
| Alkermes, Inc. | $29.61 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120456971 | CMS |
| Alkermes, Inc. | $14.00 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120456973 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $29.06 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143183340 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.57 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137469491 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.05 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137469495 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.